Senior MSL, Rare Epilepsies — Field Medical Leader

Lundbeck; Dallas (TX); À distance; USD 190 000 - 220 000; Plein temps

Résumé du poste

Lundbeck seeks a Senior Medical Science Liaison for Rare Epilepsies to lead field-based scientific engagement across multiple U.S. regions. You will partner with external experts, advance disease education, and support evidence strategy while ensuring compliant documentation and cross-functional collaboration.

The role emphasizes strategic leadership, scientific depth, and the ability to generate actionable insights that shape NeuroRare medical strategy and launch readiness.

Qualifications

• Advanced degree in health or life sciences.
• ≥5 years healthcare or related experience.
• ≥2 years field Medical Affairs experience in pharma/biotech.
• Experience supporting pre-launch assets and KOL mapping.
• Ability to translate complex data into actionable insights.

Responsabilités

• Establish and sustain long-term scientific partnerships with KOLs and investigators.
• Generate pre-launch insights and test value narratives with external experts.
• Synthesize insights for evidence strategy, publications, and education.
• Document insights in CRM per quality standards and regulatory requirements.
• Collaborate with Medical Directors and cross-functional teams to align field activities.

Connaissances

KOL engagement

Scientific communication

Cross-functional collaboration

Pre-launch assets

Data interpretation

CRM documentation

Driver's license

Formation

Advanced life sciences degree (MS/PhD/MD/DO/PharmD)

Doctoral degree preferred

MD/DO/PharmD/PhD or equivalent

Outils

Microsoft Office

Description du poste

Lundbeck seeks a Senior Medical Science Liaison for Rare Epilepsies to lead field-based scientific engagement across multiple U.S. regions. You will partner with external experts, advance disease education, and support evidence strategy while ensuring compliant documentation and cross-functional collaboration.

The role emphasizes strategic leadership, scientific depth, and the ability to generate actionable insights that shape NeuroRare medical strategy and launch readiness.